Log-In Email:    Password:    
  Remember me
Register  |  Forgot Password?  |  Change Password  |  Update Email
Closing in on Cloning
Don't expect an honest debate as the legislative fight heats up.
by Wesley J. Smith
01/14/2002, Volume 007, Issue 17

Increase Font Size

 | 

Printer-Friendly

 | 

Email a Friend

 | 

Respond to this article



THE BRAVE NEW WORLD ORDER is hurtling toward us at Mach speed. With the announcement by Advanced Cell Technology that it has created the first human clones and developed them into six-cell embryos, the country finds itself at an ethical point of no return. Either Congress will ban human cloning, or human cloning will soon be a fait accompli.

With cloning--and its first cousin, embryonic stem cell research--biotech companies are embarked upon a radical enterprise. They intend to make vast fortunes by patenting and marketing products derived from the destruction of human life. If they succeed, certain categories of humanity will be reduced to a commodity with no greater moral standing than penicillin mold. For those who doubt the objectifying intent of this research, note the language of an October 1, 2001, press release by the Geron Corp., crowing that one of its recent research breakthroughs "greatly facilitates the development of scalable manufacturing processes to enable commercialization of hES (human embryonic stem) cell-based products."

How did we get this far down the slippery slope this fast? After all, it has been only a few months since President Bush supposedly settled the stem cell debate by permitting limited federal funding of research using existing stem cell lines derived from human embryos. But as the Spanish Civil War was really just the opening engagement of World War II, the controversy over embryonic stem cell research can now be seen as merely a precursor to the greater clash over cloning about to unfold.

The struggle over embryonic

stem cell research began less than two years ago when biotech companies and their allies within the bioethics movement convinced President Clinton to open the spigot of federal funding. Clinton was willing, but he had a significant legal problem to overcome. Extracting stem cells kills embryos and federal law (the Dickey Amendment) explicitly prohibits federal funding for destructive embryonic research.

What to do? Clinton's bioethics commission recommended a Clintonian approach: Simply use private money to pay for destruction of the embryos and the extraction of their stem cells. After that, the federal government could pick up the tab. Clinton signed the order shortly before leaving office, and in doing so plopped George W. Bush right onto the hot griddle of an unwanted moral controversy.

Fulfilling his campaign promise to oppose embryonic stem cell research, President Bush promptly suspended Clinton's executive order, sparking a furious, three-pronged political counterattack. First, making a strong appeal to the pragmatism that is central to the American character, promoters of embryonic stem cell research promised that only unwanted embryos left over from in vitro fertilization procedures and due to be destroyed would be used in the research. Since these embryos were doomed in any event, the argument went, we might as well get some use out of them.

The second prong consisted of junk science. Proponents of embryonic stem cell research, such as Senator Orrin Hatch, argued that the embryos in question weren't really the early stages of human life because they would never be implanted. "Life begins in a womb, not in a Petri dish," Hatch said. Others assured squeamish Americans that these frozen humans "no larger than the period at the end of this sentence," as the pro-stem cell research propaganda had it, were actually "pre-embryos," cells of no significant moral concern.
Val:Y


CONTINUED
1 2  Next >
Print This Article


Search   Subscribe   Subscribers Only   FAQ   Advertise   Store   Newsletter
Contact   About Us   Site Map   Privacy Policy